通过调节CXCL2表达,EGCG通过抑制NET介导的ROS产生来缓解脂多糖诱导的败血性休克
Xiao Wang1, Fantuo Kong1, Qian Liu1
1Department of Emergency, Harrison International Peace Hospital, 180Renmin East Road, Hengshui, 053000, Hebei, China.
Biochemical genetics
|July 16, 2025
概括
化学基因连接体2 (CXCL2) 通过中性细胞外细胞陷 (NETs) 和活性氧物种 (ROS) 驱动性冲击中的炎症. 乙甲基-3-酸盐 (EGCG) 通过向CXCL2.2来减少败血栓冲击损伤.
科学领域:
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 中性粒细胞外细胞陷 (NETs) 和反应性氧物种 (ROS) 导致败血性休克时的器官衰竭.
- 化学因子 (C-X-C动机) 配体2 (CXCL2) 与NET形成和急性肺损伤有关.
研究的目的:
- 研究CXCL2作为败血症休克治疗点.
- 通过准CXCL2.2,确定是否能提供抗性休克的保护.
主要方法:
- 生物信息学分析和RT-qPCR用于评估败血症休克患者和老鼠的CXCL2表达.
- 使用人类中性粒细胞进行体外研究,以评估CXCL2在NET和ROS产生中的作用.
- 在接受EGCG治疗的败血性大鼠体内实验中测量CXCL2,NET,ROS和炎症标志物.
主要成果:
- 在败血症休克患者和老鼠中,CXCL2表达升高,与增加的NETs和促炎细胞因子相关.
- 在中性粒细胞中击败CXCL2减少了醇酸 (PMA) 诱导的NET和ROS.
- 在败血症大鼠中,EGCG治疗降低了CXCL2水平,抑制了NET和炎症,并减少了ROS的产生.
- EGCG的保护作用是通过降低CXCL2的调节来调节的,而CXCL2过度表达则会逆转.
结论:
- 在败血症休克中,CXCL2促进NET介导的ROS产生.
- 通过准CXCL2,EGCG减轻了败血性休克损伤,突出了其作为治疗剂的潜力.
- CXCL2代表了一种有前途的治疗标,用于败血性休克治疗.
相关概念视频
Gene Regulation in Microbial Communities: Quorum Sensing
96
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
96
Formation of Lipopolysaccharides
104
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
104


